SPEC PerkinElmer 10.13
|Articles|September 1, 2013

Spectroscopy

  • Spectroscopy-09-01-2013
  • Volume 28
  • Issue 9

Market Profile: Raman Spectroscopy in the Pharmaceutical Industry

Raman spectroscopy has developed into a key analytical tool for the pharmaceutical industry.

Raman spectroscopy has developed into a key analytical tool for the pharmaceutical industry. Both portable and benchtop Raman systems are now widely used for applications in the pharmaceutical industry. Despite a challenging economy, demand from the pharmaceutical industry is holding its own and should return to typical growth rates by next year.

Laboratory and portable Raman - pharmaceutical vendor share, 2012.

Within the pharmaceutical industry, one of the biggest applications now is the identification of incoming raw materials and finished product inspection, for which there are numerous new portable and handheld models available for on-dock or production area analysis. The other major application is the analysis of polymorphs and salt forms in both quality control (QC) and product development, variations of which can lead to dramatically different performance of a pharmaceutical product.

Worldwide demand for laboratory and portable Raman spectroscopy instrumentation from the pharmaceutical industry was about $36 million in 2012. Global economic conditions and major cuts in government spending will clearly make 2013 a challenging year for the overall Raman market. However, the numerous new product introductions and market entrants over the last two years will help keep demand from the pharmaceutical industry in positive territory in 2013, if only slightly, until much stronger growth returns, most likely in 2014.

The foregoing data were extracted from SDi's market analysis and perspectives report titled The Global Assessment Report, 12th Edition: The Laboratory Life Science and Analytical Instrument Industry, October 2012. For more information, visit www.strategic-directions.com

Articles in this issue


Related to this article

FACSS 2026 Award Interviews ©  Erin -chronicles-stock.adobe.com
Eight FACSS award winners at SciX 2026, One LIBS trailblazer. Forty-eight questions. And not one of them is a softball. Award season in spectroscopy usually means polite applause, a plaque, and a photo. We're not completely interested only in the award sessions. The eight scientists honored at SciX 2026 in Sparks, Nevada, along with LIBS researcher Alessandro De Giacomo, are pushing Raman into operating rooms, flying LIBS on drones, reading chemistry off Mars, and tracing toxic metals downwind of industrial sites. Their work makes big claims. In the coming days, Spectroscopy will sit down with eight of these researchers and ask whether those claims hold up. The interviews that follow won't just celebrate. They'll press on the gaps between simulation and experiment, between the lab bench and the clinic, and between a clever paper and an instrument someone will actually buy and use.
Spectral Frontiers: Past the Diffraction Limit (FT-IR Spectroscopy)
Fourier-transform infrared (FT-IR) spectroscopy, long the workhorse of molecular fingerprinting, is being reinvented by photothermal detection schemes and quantum cascade laser (QCL) sources that push spatial resolution and analysis speed far beyond classical dispersive and interferometric limits. New instrumentation such as optical photothermal infrared (O-PTIR) microscopy and laser direct infrared (LDIR) chemical imaging is enabling sub-micron, label-free chemical mapping of biological, environmental, and pharmaceutical samples. This article reviews the latest FT-IR-adjacent technologies, recent patents, and research driving the field, featuring perspectives from the scientists and instrument developers advancing the technique.